patternox ltdis a new Israeli start-up that developed an innovative scanner, capable of detecting precancerous skin deformations much earlier than any other scanner in the market with a high rate of accuracy. This detection does not rely on the ubiquitous mole color change but rather on deformations occurring below the skin surface. The technology (patent pending, PCT) combines innovative electro-optics with artificial intelligence (in Dev) to achieve this breakthrough. MVP of the PatScope scanner has already been used by dermatologists to successfully achieve early-stage detection of skin deformations as cancer and cosmetic problems, in trials at SKINCENTER, USA. Empowered by DLLD (Deep Learning for Lesion Distortion).

 

accomplished to date

✔ Won a contest by Vision-Elements (AI).

✔ Clinical trial with over 400 scans.

✔ Regulatory strategy. GSAP training (https://www.gsap.co.il).

✔ PCT patent submission 2022. 

✔ New PatScope Scanner with its Software and database.

✔ Business plan, business model.

✔ New electro-optics laboratory.

✔ Conferences presentations.

✔ Proposal to Space agency to investigate astronaut's skin degradation under microgravity conditions.

 

business model

✔  Sales of the scanner (physicians and home use) as standalone or adapter for smartphones

✔  Software analysis and management

✔  Unique AI for lesion distortion as decision support (SaaS)

✔  Reimbursement.

 

According to our Regulatory Pathway, PATTERNOX shall expect CE approval and FDA approval.